SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000895345-22-000182
Filing Date
2022-02-14
Accepted
2022-02-14 10:45:44
Documents
1
Group Members
ALLEGHENY NEW MOUNTAIN PARTNERS, L.P.NEW MOUNTAIN AFFILIATED INVESTORS II, L.P.NEW MOUNTAIN CAPITAL GROUP, L.P.NEW MOUNTAIN CAPITAL, L.L.C.NEW MOUNTAIN PARTNERS II (AIV-A), L.P.NEW MOUNTAIN PARTNERS II (AIV-B), L.P.NM HOLDINGS GP, L.L.C.STEVEN B. KLINSKY

Document Format Files

Seq Description Document Type Size
1 ff791750_13ga-bellerophon.htm SC 13G/A 292199
  Complete submission text file 0000895345-22-000182.txt   294208
Mailing Address 787 SEVENTH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE 49TH FLOOR NEW YORK NY 10019 212-720-0300
New Mountain Investments II, LLC (Filed by) CIK: 0001415950 (see all company filings)

IRS No.: 900173275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88741 | Film No.: 22626962
SIC: 2834 Pharmaceutical Preparations